Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug Delivery

Authors:

Abstract
Poly(amidoamine) dendrimer (PAMAM) is well known for its high efficiency as a drug delivery vehicle. However, the intrinsic cytotoxicity and inherent lack of a detectable signal to facilitate tracking have impeded its practical applications. Herein, we have developed a novel label-free fluorescent and biocompatible PAMAM derivative by simple surface modification of PAMAM using acetaldehyde. The modified PAMAM possessed a strong green fluorescence, which was generated by the C=N bonds of the resulting Schiff Bases via n-π* transition, while the intrinsic cytotoxicity of PAMAM was simultaneously ameliorated. Through further PEGylation, the fluorescent PAMAM demonstrated excellent intracellular tracking in human melanoma SKMEL28 cells. In addition, our PEGylated fluorescent PAMAM derivative achieved enhanced loading and delivery efficiency of the anticancer drug doxorubicin (DOX) compared to the original PAMAM. Importantly, the accelerated kinetics of DOX-encapsulated fluorescent PAMAM nanocomposites in an acidic environment facilitated intracellular drug release, demonstrating comparable cytotoxicity to that of the free-form doxorubicin hydrochloride (DOX·HCl) against melanoma cells. Overall, our fluorescent PAMAM derivative offers a new opportunity of traceable and controlled delivery for DOX and other drugs of potential clinical importance.
Funding Information
  • University of Queensland
  • Department of Education and Training (69172018)
  • National Natural Science Foundation of China (31600809, U1604177)
  • Macquarie University
  • Queensland Brain Institute
  • Judith Jane Mason and Harold Stannett Williams Memorial Foundation (MAS2017F034)
  • Ministry of Science and Technology of the People's Republic of China (2018YFA0209800)
  • National Health and Medical Research Council (APP 1140386, APP 1111611)

This publication has 44 references indexed in Scilit: